Premium
Use of fluorescein isothiocyanate‐human serum albumin for the intravesical photodiagnosis of non‐muscle‐invasive bladder cancer: an in vitro study using multicellular spheroids composed of normal human urothelial and urothelial cell carcinoma cell lines
Author(s) -
Roelants Mieke,
Van Cleynenbreugel Ben,
Van Poppel Hendrik,
Lerut Evelyne,
de Witte Peter A.M.
Publication year - 2011
Publication title -
bju international
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.773
H-Index - 148
eISSN - 1464-410X
pISSN - 1464-4096
DOI - 10.1111/j.1464-410x.2010.09951.x
Subject(s) - fluorescein isothiocyanate , spheroid , urothelium , fluorescein , in vivo , in vitro , human serum albumin , bladder cancer , urothelial cell , pathology , albumin , chemistry , urinary bladder , cancer , medicine , urology , biology , biochemistry , fluorescence , physics , microbiology and biotechnology , quantum mechanics
OBJECTIVE• To evaluate human serum albumin (HSA), fluorescently labelled with fluorescein isothiocyanate (FITC), as a potential intravesical photodiagnostic method for the early detection of non‐muscle‐invasive bladder cancer.PATIENTS AND METHODS• By using multicellular spheroids prepared from normal human urothelial (NHU) cells and from different urothelial cell carcinoma (UCC) cell lines (T24, J82), we simulated three‐dimensionally the normal urothelium and non‐muscle‐invasive UCCs present in the bladder of patients. • The distribution of FITC‐HSA in these spheroids was investigated.RESULTS• Our data showed that fluorescently labelled albumin is quite evenly dispersed throughout the spheroids. However, in the case of the 10 mg/mL incubations, the fluorescence intensity seems to increase slightly towards the spheroid core. • Using 1 mg/mL, the penetration of FITC‐HSA in T24 differed significantly from the penetration in NHU spheroids, but this was not the case for J82 spheroids. • When the concentration of FITC‐HSA was increased 10‐fold, all UCC spheroids exhibited a significantly different accumulation of FITC‐HSA.CONCLUSIONS• As spheroids represent a suitable in vitro model for predicting the in vivo behaviour of compounds, our data suggest that FITC‐HSA could be used for the early detection of non‐muscle‐invasive bladder cancer. • Human serum albumin conjugates of new or already available intravesical drugs could be generated to create alternative bladder cancer therapies with increased selectivity.